GNPTAB and B-cell chronic lymphocytic leukemia: Interestingly, we recently showed that CD34+/CD38− cells from CLL patients expressed NOTCH1 receptor and displayed higher levels of the active NOTCH1-ICD than healthy donors, independent of the NOTCH1 mutational status (129).